Strumento inattivo

Azioni Response Biomedical Corp

Azioni

Durata

Periodo

Stile

Response Biomedical Corp. : Completes Going-Private Transaction	29/11/16
Response Biomedical : Announces Third Quarter Results	14/11/16
Response Biomedical Corp. : Announces Third Quarter 2016 Financial Results and Update on Going-Private Transaction	10/11/16
Response Biomedical Corp. : Receives Court Approval of Going-Private Transaction	19/09/16
Response Biomedical Corp. : Receives Shareholder Approval of Going-Private Transaction	16/09/16

Dirigenti	Titolo	Età	Da
Barbara Kinnaird-Steen CEO	Chief Executive Officer	56	-
Anastasios Tsonis DFI	Director of Finance/CFO	44	01/01/11
Eric Whitters COO	Chief Operating Officer	-	-

Amministratori	Titolo	Età	Da
Barbara Kinnaird-Steen CEO	Chief Executive Officer	56	-

Settore

	Variaz. 1 gen.	Capi.
BIOMÉRIEUX	-9,74%	11,48 Mrd
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-9,80%	7,64 Mrd
LANTHEUS HOLDINGS, INC.	+27,84%	5,49 Mrd
AUTOBIO DIAGNOSTICS CO., LTD.	-15,47%	3,86 Mrd
ANDON HEALTH CO., LTD.	+8,47%	2,61 Mrd
10X GENOMICS, INC.	-63,81%	2,42 Mrd
VITROLIFE AB	-9,24%	2,27 Mrd
MYRIAD GENETICS, INC.	+21,21%	2,1 Mrd
GUANGZHOU WONDFO BIOTECH CO.,LTD	-9,38%	1,76 Mrd